Vorinostat, Paclitaxel, and Bevacizumab in Treating Patients With Metastatic Breast Cancer and/or Breast Cancer That Has Recurred in the Chest Wall and Cannot be Removed by Surgery

This study is ongoing, but not recruiting participants.

Study NCT00368875 Information provided by National Cancer Institute (NCI)

First Received: August 24, 2006 Last Updated: October 13, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)